Submissions

Login or Register to make a submission.

Author Guidelines

General

(1) Abstracts are accepted for the oral and paper-based poster session.

(2) Both oral and poster presentations will be presented on July 1, 2026.

(3) Presenters are required to deliver their presentations and respond to audience questions within the allotted time.

Topics

Abstracts must be in the areas of:

  • TB diagnostics

  • TB screening

  • TB treatment innovation

  • TB management

  • TB and comorbidities

  • TB prevention

  • AI-assisted technologies for TB

  • Maternal and child TB

  • TB policy and clinical implementation

  • Health and well-being post TB

  • TB and nutrition

Authors 

(1) Authors’ names and affiliations are entered in the “Contributor” step

(2) The corresponding author is responsible for the abstract content. They are the contact person for submission and communication purposes and they are also responsible for disseminating information related to the abstract to the co-authors. 

(3) Assign one of the authors as the corresponding author by clicking the “Set Primary Contact” button.

(4) Please note that only one person will be allowed to present the abstract. The presenter could be from the first author, co-author, or corresponding author.

(5) The presenting author must be registered to attend the event.

(6) As they submit an abstract, authors have to be aware that they must register for the conference if they have an abstract accepted, and be available on-site to present the presentation.

(7) Once the abstract is submitted and reviewed, the list of co-authors can no longer be amended.

Originality and linguistic accuracy

(1) Abstracts must contain original data, be free of plagiarism, and be written and submitted in English.

(2) The linguistic accuracy of the abstract is the responsibility of the authors.

(3) The abstract must not have been published or presented in another conference/event.

Submission Preparation Checklist

Abstracts Formatting

(1) The abstract is only accepted for original research.

(2) The abstract title should begin with a capital letter followed by lowercase lettering with no more than 25 words (110 characters and spaces). Capital letters are only applied to the first word, acronyms, and proper nouns.

(3) The body of text can be a maximum of 300 words and is permitted to include one figure and/or one table per abstract.

(4) Abstracts should be written in a structured format and include: Background, Methods, Results, and Conclusion.

(5) Please note that affiliations do not count as part of the 300 words.

(6) Abstracts must be submitted in English. Abstracts submitted in a language other than English will be rejected.

(7) Authors are responsible for proofreading and submitting an abstract without language and formatting errors.

(8) Abbreviations and acronyms should be written out in full at the first mention in the text.

(9) Revisions will not be permitted after the abstract is submitted.

Copyright Notice

(1) Authors are required to write an original abstract that fulfills accepted criteria for copyright purposes. 

(2) By submitting an abstract, all authors attest that the abstract submitted has not been previously published elsewhere and transfers, assigns, or otherwise conveys all copyright ownership, including any and all rights incidental thereto, exclusively to the committee and AMSN.

(3) If an author chooses to submit information from an abstract that has previously been presented and/or published, all data must be updated, current, and rewritten in a manner that does not infringe on international copyright laws. Authors are responsible for obtaining permission to include any copyrighted material in their abstract presentations. All authors will be required to agree to a copyright assignment statement when submitting an abstract.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.